vs

Side-by-side financial comparison of NOODLES & Co (NDLS) and TREACE MEDICAL CONCEPTS, INC. (TMCI). Click either name above to swap in a different company.

NOODLES & Co is the larger business by last-quarter revenue ($122.1M vs $62.5M, roughly 2.0× TREACE MEDICAL CONCEPTS, INC.). NOODLES & Co runs the higher net margin — -7.5% vs -15.0%, a 7.5% gap on every dollar of revenue. On growth, NOODLES & Co posted the faster year-over-year revenue change (-4.1% vs -9.0%). NOODLES & Co produced more free cash flow last quarter ($-2.8M vs $-10.4M). Over the past eight quarters, TREACE MEDICAL CONCEPTS, INC.'s revenue compounded faster (10.6% CAGR vs -1.2%).

Noodles & Company is an American fast-casual restaurant that offers international and American noodle dishes in addition to soups and salads. Noodles & Company was founded in 1995 by Aaron Kennedy and is headquartered in Broomfield, Colorado. The company went public in 2013 and recorded a $457 million revenue in 2017. In mid-2022, there were 458 Noodles & Company locations across 31 states.

Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.

NDLS vs TMCI — Head-to-Head

Bigger by revenue
NDLS
NDLS
2.0× larger
NDLS
$122.1M
$62.5M
TMCI
Growing faster (revenue YoY)
NDLS
NDLS
+4.9% gap
NDLS
-4.1%
-9.0%
TMCI
Higher net margin
NDLS
NDLS
7.5% more per $
NDLS
-7.5%
-15.0%
TMCI
More free cash flow
NDLS
NDLS
$7.6M more FCF
NDLS
$-2.8M
$-10.4M
TMCI
Faster 2-yr revenue CAGR
TMCI
TMCI
Annualised
TMCI
10.6%
-1.2%
NDLS

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
NDLS
NDLS
TMCI
TMCI
Revenue
$122.1M
$62.5M
Net Profit
$-9.2M
$-9.4M
Gross Margin
80.6%
Operating Margin
-5.2%
-9.5%
Net Margin
-7.5%
-15.0%
Revenue YoY
-4.1%
-9.0%
Net Profit YoY
32.8%
-1775.0%
EPS (diluted)
$-0.20
$-0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NDLS
NDLS
TMCI
TMCI
Q4 25
$62.5M
Q3 25
$122.1M
$50.2M
Q2 25
$123.8M
$47.4M
Q1 25
$52.6M
Q4 24
$122.8M
$68.7M
Q3 24
$127.4M
$45.1M
Q2 24
$121.4M
$44.5M
Q1 24
$124.3M
$51.1M
Net Profit
NDLS
NDLS
TMCI
TMCI
Q4 25
$-9.4M
Q3 25
$-9.2M
$-16.3M
Q2 25
$-9.1M
$-17.4M
Q1 25
$-15.9M
Q4 24
$-6.8M
$-501.0K
Q3 24
$-13.6M
$-15.4M
Q2 24
$-6.1M
$-21.2M
Q1 24
$-6.1M
$-18.7M
Gross Margin
NDLS
NDLS
TMCI
TMCI
Q4 25
80.6%
Q3 25
79.1%
Q2 25
79.7%
Q1 25
79.7%
Q4 24
80.7%
Q3 24
80.1%
Q2 24
80.2%
Q1 24
80.2%
Operating Margin
NDLS
NDLS
TMCI
TMCI
Q4 25
-9.5%
Q3 25
-5.2%
-31.2%
Q2 25
-5.2%
-35.8%
Q1 25
-29.6%
Q4 24
-3.9%
-0.3%
Q3 24
-9.0%
-33.6%
Q2 24
-3.4%
-48.1%
Q1 24
-3.7%
-37.1%
Net Margin
NDLS
NDLS
TMCI
TMCI
Q4 25
-15.0%
Q3 25
-7.5%
-32.4%
Q2 25
-7.3%
-36.7%
Q1 25
-30.3%
Q4 24
-5.5%
-0.7%
Q3 24
-10.7%
-34.1%
Q2 24
-5.1%
-47.7%
Q1 24
-4.9%
-36.5%
EPS (diluted)
NDLS
NDLS
TMCI
TMCI
Q4 25
$-0.14
Q3 25
$-0.20
$-0.26
Q2 25
$-0.20
$-0.28
Q1 25
$-0.25
Q4 24
$-0.15
$-0.01
Q3 24
$-0.30
$-0.25
Q2 24
$-0.14
$-0.34
Q1 24
$-1.64
$-0.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NDLS
NDLS
TMCI
TMCI
Cash + ST InvestmentsLiquidity on hand
$4.7M
$48.4M
Total DebtLower is stronger
$55.6M
Stockholders' EquityBook value
$-38.9M
$87.3M
Total Assets
$280.6M
$190.6M
Debt / EquityLower = less leverage
0.64×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NDLS
NDLS
TMCI
TMCI
Q4 25
$48.4M
Q3 25
$4.7M
$57.4M
Q2 25
$1.4M
$69.3M
Q1 25
$76.1M
Q4 24
$3.3M
$75.7M
Q3 24
$1.8M
$82.8M
Q2 24
$1.3M
$95.0M
Q1 24
$3.0M
$110.0M
Total Debt
NDLS
NDLS
TMCI
TMCI
Q4 25
$55.6M
Q3 25
$53.5M
Q2 25
$53.5M
Q1 25
$53.4M
Q4 24
$53.3M
Q3 24
$53.2M
Q2 24
$53.2M
Q1 24
$53.1M
Stockholders' Equity
NDLS
NDLS
TMCI
TMCI
Q4 25
$87.3M
Q3 25
$-38.9M
$89.2M
Q2 25
$-13.9M
$97.6M
Q1 25
$105.3M
Q4 24
$3.7M
$112.9M
Q3 24
$9.6M
$104.9M
Q2 24
$21.9M
$112.1M
Q1 24
$27.2M
$126.4M
Total Assets
NDLS
NDLS
TMCI
TMCI
Q4 25
$190.6M
Q3 25
$280.6M
$196.6M
Q2 25
$319.4M
$206.4M
Q1 25
$205.8M
Q4 24
$340.5M
$217.1M
Q3 24
$346.3M
$212.9M
Q2 24
$360.4M
$226.1M
Q1 24
$368.1M
$242.7M
Debt / Equity
NDLS
NDLS
TMCI
TMCI
Q4 25
0.64×
Q3 25
0.60×
Q2 25
0.55×
Q1 25
0.51×
Q4 24
0.47×
Q3 24
0.51×
Q2 24
0.47×
Q1 24
0.42×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NDLS
NDLS
TMCI
TMCI
Operating Cash FlowLast quarter
$4.3M
$-8.0M
Free Cash FlowOCF − Capex
$-2.8M
$-10.4M
FCF MarginFCF / Revenue
-2.3%
-16.7%
Capex IntensityCapex / Revenue
5.8%
3.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-7.5M
$-29.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NDLS
NDLS
TMCI
TMCI
Q4 25
$-8.0M
Q3 25
$4.3M
$-9.1M
Q2 25
$4.0M
$-3.0M
Q1 25
$4.2M
Q4 24
$5.8M
$-4.2M
Q3 24
$4.7M
$-11.8M
Q2 24
$7.0M
$-13.9M
Q1 24
$164.0K
$-7.2M
Free Cash Flow
NDLS
NDLS
TMCI
TMCI
Q4 25
$-10.4M
Q3 25
$-2.8M
$-11.9M
Q2 25
$1.1M
$-7.8M
Q1 25
$655.0K
Q4 24
$-1.3M
$-7.3M
Q3 24
$-4.5M
$-14.7M
Q2 24
$-1.6M
$-15.6M
Q1 24
$-15.2M
$-11.1M
FCF Margin
NDLS
NDLS
TMCI
TMCI
Q4 25
-16.7%
Q3 25
-2.3%
-23.7%
Q2 25
0.9%
-16.5%
Q1 25
1.2%
Q4 24
-1.1%
-10.6%
Q3 24
-3.5%
-32.6%
Q2 24
-1.4%
-35.2%
Q1 24
-12.2%
-21.8%
Capex Intensity
NDLS
NDLS
TMCI
TMCI
Q4 25
3.8%
Q3 25
5.8%
5.6%
Q2 25
2.4%
10.1%
Q1 25
6.7%
Q4 24
5.8%
4.5%
Q3 24
7.2%
6.4%
Q2 24
7.1%
3.9%
Q1 24
12.3%
7.7%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NDLS
NDLS

Food And Beverage$119.6M98%
Franchise$2.5M2%

TMCI
TMCI

Segment breakdown not available.

Related Comparisons